| Year |
Title |
Altmetric |
| 2022
|
Clinical risk factors for admission with Pseudomonas and multidrug-resistant Pseudomonas community-acquired pneumonia.
Antimicrobial Resistance and Infection Control.
11.
2022
|
|
| 2022
|
Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort An Observational Cohort Study.
American Journal of Respiratory and Critical Care Medicine.
206:554-562.
2022
|
|
| 2022
|
Telemedicine for Patients with Chronic Pulmonary Diseases in the COVID-19 Era and Beyond.
Annals of the American Thoracic Society.
19:1448-1450.
2022
|
|
| 2022
|
Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary Disease.
American Journal of Respiratory and Critical Care Medicine.
206:427-439.
2022
|
|
| 2022
|
Mind the Gap: Addressing Cardiovascular Disease in Chronic Obstructive Pulmonary Disease.
Annals of the American Thoracic Society.
19:1093-1095.
2022
|
|
| 2022
|
A Metabolomic Severity Score for Airflow Obstruction and Emphysema.
Metabolites.
12.
2022
|
|
| 2022
|
Significance of FEV3/FEV6 in Recognition of Early Airway Disease in Smokers at Risk of Development of COPD: Analysis of the SPIROMICS Cohort.
Chest.
161:949-959.
2022
|
|
| 2022
|
Comparative Impact of Depressive Symptoms and FEV1% on Chronic Obstructive Pulmonary Disease.
Annals of the American Thoracic Society.
19:171-178.
2022
|
|
| 2022
|
Characterizing COPD Symptom Variability in the Stable State Utilizing the Evaluating Respiratory Symptoms in COPD Instrument.
Chronic obstructive pulmonary diseases (Miami, Fla.).
9:195-208.
2022
|
|
| 2022
|
Clinically Significant and Comorbid Anxiety and Depression Symptoms Predict Severe Respiratory Exacerbations in Smokers: A Post Hoc Analysis of the COPDGene and SPIROMICS Cohorts.
Annals of the American Thoracic Society.
19:143-146.
2022
|
|
| 2022
|
Outcome expectancies and resistance self-efficacy mediate the relationship between asthma diagnosis and e-cigarette use among youth and young adults.
Journal of Asthma.
2022
|
|
| 2021
|
Association of plasma mitochondrial DNA with COPD severity and progression in the SPIROMICS cohort.
Respiratory Research.
22.
2021
|
|
| 2021
|
Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium
2021
|
|
| 2021
|
Genetic variation in genes regulating skeletal muscle regeneration and tissue remodelling associated with weight loss in chronic obstructive pulmonary disease.
Journal of Cachexia, Sarcopenia and Muscle.
12:1803-1817.
2021
|
|
| 2021
|
Secondary polycythemia in chronic obstructive pulmonary disease: prevalence and risk factors.
BMC Pulmonary Medicine.
21.
2021
|
|
| 2021
|
Small Airway Disease and Emphysema Are Associated with Future Exacerbations in Smokers with CT-derived Bronchiectasis and COPD: Results from the COPDGene Cohort..
Radiology.
300:706-714.
2021
|
|
| 2021
|
Pulmonary artery enlargement is associated with exacerbations and mortality in ever-smokers with preserved ratio impaired spirometry.
American Journal of Respiratory and Critical Care Medicine.
204:481-485.
2021
|
|
| 2021
|
Pulmonary Arterial Pruning and Longitudinal Change in Percent Emphysema and Lung Function: The Genetic Epidemiology of COPD Study.
Chest.
160:470-480.
2021
|
|
| 2021
|
ST6GAL1 and α2-6 Sialylation Regulates IL-6 Expression and Secretion in Chronic Obstructive Pulmonary Disease.
Frontiers in Immunology.
12.
2021
|
|
| 2021
|
The immunological response among COVID-19 patients with acute respiratory distress syndrome.
Journal of Infection and Public Health.
14:954-959.
2021
|
|
| 2021
|
Binge drinking moderates the association between chronic lung disease and e-cigarette use
2021
|
|
| 2021
|
Prolyl endopeptidase contributes to early neutrophilic inflammation in acute myocardial transplant rejection.
JCI Insight.
6.
2021
|
|
| 2021
|
Supportive care of right ventricular failure due to fat embolism syndrome.
Respiratory Medicine Case Reports.
34.
2021
|
|
| 2020
|
Clinical Phenotypes of Atopy and Asthma in COPD: A Meta-analysis of SPIROMICS and COPDGene.
Chest.
158:2333-2345.
2020
|
|
| 2020
|
Current smoking with or without chronic bronchitis is independently associated with goblet cell hyperplasia in healthy smokers and COPD subjects.
Scientific Reports.
10.
2020
|
|
| 2020
|
Increased airway iron parameters and risk for exacerbation in COPD: an analysis from SPIROMICS.
Scientific Reports.
10.
2020
|
|
| 2020
|
Machine Learning and Prediction of All-Cause Mortality in COPD.
Chest.
158:952-964.
2020
|
|
| 2020
|
Practical recommendations for the use of beta-blockers in chronic obstructive pulmonary disease.
Expert Review of Respiratory Medicine.
14:671-678.
2020
|
|
| 2020
|
Effect of zephyr endobronchial valves on dyspnea, activity levels, and quality of life at one year: Results from a randomized clinical trial.
Annals of the American Thoracic Society.
17:829-838.
2020
|
|
| 2020
|
Smaller left ventricle size at noncontrast ct is associated with lower mortality in copdgene participants.
Radiology.
296:208-215.
2020
|
|
| 2020
|
Heme metabolism genes Downregulated in COPD Cachexia.
Respiratory Research.
21.
2020
|
|
| 2020
|
POINT: Are Eosinophils Useful for the Management of COPD? Yes.
Chest.
157:1073-1075.
2020
|
|
| 2020
|
Rebuttal From Drs Wade and Wells.
Chest.
157:1078-1079.
2020
|
|
| 2020
|
Associations Among 25-Hydroxyvitamin D Levels, Lung Function, and Exacerbation Outcomes in COPD: An Analysis of the SPIROMICS Cohort.
Chest.
157:856-865.
2020
|
|
| 2020
|
Association of urine mitochondrial DNA with clinical measures of COPD in the SPIROMICS cohort.
JCI Insight.
5.
2020
|
|
| 2020
|
Pulmonary artery enlargement and mortality risk in moderate to severe COPD: Results from COPDGene.
European Respiratory Journal.
55.
2020
|
|
| 2020
|
Pulmonary artery enlargement is associated with pulmonary hypertension and decreased survival in severe cystic fibrosis: A cohort study.
PLoS One.
15.
2020
|
|
| 2020
|
Plasma cathelicidin is independently associated with reduced lung function in COPD: Analysis of the subpopulations and intermediate outcome measures in COPD study cohort.
Chronic obstructive pulmonary diseases (Miami, Fla.).
7:370-381.
2020
|
|
| 2019
|
Metoprolol for the prevention of acute exacerbations of COPD.
New England Journal of Medicine.
381:2304-2314.
2019
|
|
| 2019
|
The matrikine acetyl-proline-glycine-proline and clinical features of COPD: Findings from SPIROMICS.
Respiratory Research.
20.
2019
|
|
| 2019
|
Radiographic lung volumes predict progression to COPD in smokers with preserved spirometry in SPIROMICS.
European Respiratory Journal.
54.
2019
|
|
| 2019
|
The St. George's Respiratory Questionnaire Definition of Chronic Bronchitis May Be a Better Predictor of COPD Exacerbations Compared With the Classic Definition.
Chest.
156:685-695.
2019
|
|
| 2019
|
Arterial vascular pruning, right ventricular size, and clinical outcomes in chronic obstructive pulmonary disease a longitudinal observational study.
American Journal of Respiratory and Critical Care Medicine.
200:454-461.
2019
|
|
| 2019
|
Bronchoalveolar lavage fluid from copd patients reveals more compounds associated with disease than matched plasma.
Metabolites.
9.
2019
|
|
| 2019
|
Clinical Epidemiology of COPD: Insights From 10 Years of the COPDGene Study.
Chest.
156:228-238.
2019
|
|
| 2019
|
Association of e-cigarette use with oral health: A populationbased cross-sectional questionnaire study.
Journal of Public Health.
41:354-361.
2019
|
|
| 2019
|
Fibroblast growth factor 23 is associated with a frequent exacerbator phenotype in COPD: A cross-sectional pilot study.
International Journal of Molecular Sciences.
20.
2019
|
|
| 2019
|
Predictors of Response to Endobronchial Coil Therapy in Patients With Advanced Emphysema.
Chest.
155:928-937.
2019
|
|
| 2019
|
Safety and tolerability of comprehensive research bronchoscopy in chronic obstructive pulmonary disease results from the SPIROMICS bronchoscopy substudy.
Annals of the American Thoracic Society.
16:439-446.
2019
|
|
| 2019
|
Aspirin Use and Respiratory Morbidity in COPD: A Propensity Score-Matched Analysis in Subpopulations and Intermediate Outcome Measures in COPD Study.
Chest.
155:519-527.
2019
|
|
| 2019
|
Activated PMN Exosomes: Pathogenic Entities Causing Matrix Destruction and Disease in the Lung.
Cell.
176:113-126.e15.
2019
|
|
| 2019
|
An airway epithelial IL-17A response signature identifies a steroid-unresponsive COPD patient subgroup.
Journal of Clinical Investigation.
129.
2019
|
|
| 2019
|
Acquired cystic fibrosis transmembrane conductance regulator dysfunction and radiographic bronchiectasis in current and former smokers: A cross-sectional study.
Annals of the American Thoracic Society.
16:150-153.
2019
|
|
| 2019
|
Clinical significance of bronchodilator responsiveness evaluated by forced vital capacity in COPD: SPIROMICS cohort analysis
2019
|
|
| 2019
|
Induced pluripotent stem cell-derived endothelial cells attenuate lipopolysaccharide-induced acute lung injury.
Journal of Applied Physiology.
127:444-456.
2019
|
|
| 2019
|
Inflammation and endothelial activation in early adulthood are associated with future emphysema: The CARDIA Lung Study.
European Respiratory Journal.
53.
2019
|
|
| 2019
|
Proline-glycine-proline peptides are critical in the development of smoke-induced emphysema.
American Journal of Respiratory Cell and Molecular Biology.
61:560-566.
2019
|
|
| 2019
|
Velocity transfer function in the right pulmonary artery and impaired cardiopulmonary reserve in COPD
2019
|
|
| 2018
|
Longitudinal phenotypes and mortality in preserved ratio impaired spirometry in the COPDGene study.
American Journal of Respiratory and Critical Care Medicine.
198:1397-1405.
2018
|
|
| 2018
|
Elevated circulating MMP-9 is linked to increased COPD exacerbation risk in SPIROMICS and COPDGene.
JCI Insight.
3.
2018
|
|
| 2018
|
Macrophage Rac2 is required to reduce the severity of cigarette smoke-induced pneumonia.
American Journal of Respiratory and Critical Care Medicine.
198:1288-1301.
2018
|
|
| 2018
|
Heme scavenging reduces pulmonary endoplasmic reticulum stress, fibrosis, and emphysema.
JCI Insight.
3.
2018
|
|
| 2018
|
COPD ground zero: small airways rather than alveoli as the initial site of injury
2018
|
|
| 2018
|
Interstitial features at chest CT enhance the deleterious effects of emphysema in the COPDGene cohort.
Radiology.
288:600-609.
2018
|
|
| 2018
|
Fibroblast growth factor 23 and Klotho contribute to airway inflammation.
European Respiratory Journal.
52.
2018
|
|
| 2018
|
NT-proBNP in stable COPD and future exacerbation risk: Analysis of the SPIROMICS cohort.
Respiratory Medicine.
140:87-93.
2018
|
|
| 2018
|
Rural residence and chronic obstructive pulmonary disease exacerbations: Analysis of the SPIROMICS cohort.
Annals of the American Thoracic Society.
15:808-815.
2018
|
|
| 2018
|
Anemia and Adverse Outcomes in a Chronic Obstructive Pulmonary Disease Population with a High Burden of Comorbidities. An Analysis from SPIROMICS..
Annals of the American Thoracic Society.
15:710-717.
2018
|
|
| 2018
|
Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease.
Journal of Allergy and Clinical Immunology.
141:2037-2047.e10.
2018
|
|
| 2018
|
Deciphering COPD and associated cardiovascular impairment
2018
|
|
| 2018
|
Sleep disruption as a predictor of quality of life among patients in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS).
Sleep.
41.
2018
|
|
| 2018
|
Smoking duration alone provides stronger risk estimates of chronic obstructive pulmonary disease than pack-years.
Thorax.
73:414-421.
2018
|
|
| 2018
|
Paratracheal paraseptal emphysema and expiratory central airway collapse in smokers.
Annals of the American Thoracic Society.
15:479-484.
2018
|
|
| 2018
|
Association of thrombocytosis with COPD morbidity: The SPIROMICS and COPDGene cohorts.
Respiratory Research.
19.
2018
|
|
| 2018
|
CT measurements of central pulmonary vasculature as predictors of severe exacerbation in COPD.
Medicine.
97.
2018
|
|
| 2018
|
Life-space mobility and clinical outcomes in COPD
2018
|
|
| 2018
|
Phenotype Detection Registry System (PheDRS) - Implementation of a Generalizable Single Institution Clinical Registry Architecture.
Proceedings / AMIA ... Annual Symposium. AMIA Symposium.
2018:847-856.
2018
|
|
| 2018
|
The use of a standardized order set reduces systemic corticosteroid dose and length of stay for individuals hospitalized with acute exacerbations of COPD: A cohort study
2018
|
|
| 2017
|
Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort
2017
|
|
| 2017
|
Cardiac morphometry on computed tomography and exacerbation reduction with β-blocker therapy in chronic obstructive pulmonary disease.
American Journal of Respiratory and Critical Care Medicine.
196:1484-1488.
2017
|
|
| 2017
|
Implications of DRG Classification in a Bundled Payment Initiative for COPD.
2017
|
|
| 2017
|
The Matrikine Acetylated Proline-Glycine-Proline Couples Vascular Inflammation and Acute Cardiac Rejection.
Scientific Reports.
7.
2017
|
|
| 2017
|
Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort
2017
|
|
| 2017
|
In Rotterdam, size really does matter: Implications of pulmonary artery enlargement on mortality.
European Respiratory Journal.
49.
2017
|
|
| 2017
|
Results of a Medicare Bundled Payments for care Improvement initiative for chronic obstructive pulmonary disease readmissions.
Annals of the American Thoracic Society.
14:643-648.
2017
|
|
| 2017
|
Ventricular Geometry From Non-contrast Non-ECG-gated CT Scans: An Imaging Marker of Cardiopulmonary Disease in Smokers.
Academic Radiology.
24:594-602.
2017
|
|
| 2017
|
Bringing Stability to the Chronic Obstructive Pulmonary Disease Patient: Clinical and Pharmacological Considerations for Frequent Exacerbators.
Drugs.
77:651-670.
2017
|
|
| 2017
|
Doxycycline improves clinical outcomes during cystic fibrosis exacerbations.
European Respiratory Journal.
49.
2017
|
|
| 2017
|
GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease.
Respiratory Research.
18.
2017
|
|
| 2017
|
Acute exacerbations and lung function loss in smokers with and without chronic obstructive pulmonary disease.
American Journal of Respiratory and Critical Care Medicine.
195:324-330.
2017
|
|
| 2017
|
Pulmonary rehabilitation improves outcomes in chronic obstructive pulmonary disease independent of disease burden.
Annals of the American Thoracic Society.
14:26-32.
2017
|
|
| 2016
|
Evaluation of Galleria mellonella larvae for studying the virulence of Streptococcus suis.
BMC Microbiology.
16:1-9.
2016
|
|
| 2016
|
Clinical, physiologic, and radiographic factors contributing to development of hypoxemia in moderate to severe COPD: A cohort study.
BMC Pulmonary Medicine.
16.
2016
|
|
| 2016
|
A ferret model of COPD-related chronic bronchitis.
JCI Insight.
1.
2016
|
|
| 2016
|
Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD.
PLoS Genetics.
12.
2016
|
|
| 2016
|
Pulmonary artery enlargement and cystic fibrosis pulmonary exacerbations: a cohort study
2016
|
|
| 2016
|
Association between functional small airway disease and FEV1 decline in chronic obstructive pulmonary disease.
American Journal of Respiratory and Critical Care Medicine.
194:178-184.
2016
|
|
| 2016
|
β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): A randomised controlled study protocol.
BMJ Open.
6.
2016
|
|
| 2016
|
Pulmonary artery enlargement is associated with cardiac injury during severe exacerbations of COPD.
Chest.
149:1197-1204.
2016
|
|
| 2016
|
Disease phenotyping in chronic obstructive pulmonary disease: The neutrophilic endotype.
Current Opinion in Pulmonary Medicine.
22:91-99.
2016
|
|
| 2016
|
Determinants of successful completion of pulmonary rehabilitation in COPD
2016
|
|
| 2016
|
Risk factors for COPD exacerbations in inhaled medication users: The COPDGene study biannual longitudinal follow-up prospective cohort.
BMC Pulmonary Medicine.
16.
2016
|
|
| 2016
|
Depression is associated with readmission for acute exacerbation of chronic obstructive pulmonary disease.
Annals of the American Thoracic Society.
13:197-203.
2016
|
|
| 2016
|
Arterial and venous pulmonary vascular morphology and their relationship to findings in cardiac magnetic resonance imaging in smokers
2016
|
|
| 2016
|
β-Blockers are associated with a reduction in COPD exacerbations.
Thorax.
71:8-14.
2016
|
|
| 2015
|
A fragment in time: Elastin peptides and progression of emphysema.
American Journal of Respiratory and Critical Care Medicine.
192:1141-1143.
2015
|
|
| 2015
|
Benefits of completing pulmonary rehabilitation in patients with asthma.
Journal of Asthma.
52:969-973.
2015
|
|
| 2015
|
A randomized, placebo-controlled trial of roflumilast effect on proline-glycine-proline and neutrophilic inflammation in chronic obstructive pulmonary disease.
American Journal of Respiratory and Critical Care Medicine.
192:934-942.
2015
|
|
| 2015
|
A randomised trial of lung sealant versus medical therapy for advanced emphysema.
European Respiratory Journal.
46:651-662.
2015
|
|
| 2015
|
Clinical and radiologic disease in smokers with normal spirometry.
JAMA Internal Medicine.
175:1539-1549.
2015
|
|
| 2015
|
MMP generated matrikines.
Matrix Biology.
44-46:122-129.
2015
|
|
| 2015
|
Pulmonary artery enlargement is associated with right ventricular dysfunction and loss of blood volume in small pulmonary vessels in chronic obstructive pulmonary disease.
Circulation: Cardiovascular Imaging.
8.
2015
|
|
| 2015
|
The matrikine N-α-PGP couples extracellular matrix fragmentation to endothelial permeability.
Science Advances.
1.
2015
|
|
| 2015
|
IREB2 and GALC are associated with pulmonary artery enlargement in chronic obstructive pulmonary disease.
American Journal of Respiratory Cell and Molecular Biology.
52:365-376.
2015
|
|
| 2014
|
Radiological correlates and clinical implications of the paradoxical lung function response to β2 agonists: An observational study
2014
|
|
| 2014
|
Cardiovascular disease in COPD: A call for action
2014
|
|
| 2014
|
Prediction of acute respiratory disease in current and former smokers with and without COPD.
Chest.
146:941-950.
2014
|
|
| 2014
|
An aberrant leukotriene A4 hydrolase-proline-glycine-proline pathway in the pathogenesis of chronic obstructive pulmonary disease.
American Journal of Respiratory and Critical Care Medicine.
190:51-61.
2014
|
|
| 2014
|
Determinants of arterial stiffness in COPD.
BMC Pulmonary Medicine.
14.
2014
|
|
| 2014
|
CT scan-measured pulmonary artery to aorta ratio and echocardiography for detecting pulmonary hypertension in severe COPD.
Chest.
145:824-832.
2014
|
|
| 2014
|
FEV1/FEV6to diagnose airflow obstruction: Comparisons with computed tomography and morbidity indices.
Annals of the American Thoracic Society.
11:335-341.
2014
|
|
| 2013
|
Sputum PGP is reduced by azithromycin treatment in patients with COPD and correlates with exacerbations.
BMJ Open.
3.
2013
|
|
| 2013
|
Pathophysiology and clinical implications of pulmonary arterial enlargement in COPD
2013
|
|
| 2013
|
Bullous Lesions After Use of a Commercial Therapeutic Hypothermia Temperature Management System: A Possible Burn Injury?.
Therapeutic Hypothermia and Temperature Management.
3:147-150.
2013
|
|
| 2013
|
Computed tomographic measures of pulmonary vascular morphology in smokers and their clinical implications.
American Journal of Respiratory and Critical Care Medicine.
188:231-239.
2013
|
|
| 2012
|
The authors reply.
New England Journal of Medicine.
367:2254-2255.
2012
|
|
| 2012
|
Pulmonary arterial enlargement and acute exacerbations of COPD.
New England Journal of Medicine.
367:913-921.
2012
|
|
| 2011
|
Recommended Reading from the University of Alabama Fellows: J. Allen Cooper, Program Director..
American Journal of Respiratory and Critical Care Medicine.
183:411-412.
2011
|
|
| 2010
|
In search of....
New England Journal of Medicine.
363:2249-2254.
2010
|
|
